MS Speaks

Multiple Sclerosis => TREATMENTS => TYSABRI (natalizumab) => Topic started by: agate on April 17, 2018, 07:05:18 am

Title: (Summary) Pathogenesis of PML and risks associated w/MS treatments--decade of lessons learned
Post by: agate on April 17, 2018, 07:05:18 am
From The Lancet Neurology, "Pathogenesis of progressive multifocal leucoencephalopathy and risks associated with treatments for multiple sclerosis: A decade of lessons learned" (May 2018):


http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30040-1/fulltext?{$trackingTag}